Home/Filings/4/0001628280-24-011738
4//SEC Filing

Waters Kevin 4

Accession 0001628280-24-011738

CIK 0001588978other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 6:05 PM ET

Size

10.1 KB

Accession

0001628280-24-011738

Insider Transaction Report

Form 4
Period: 2024-03-15
Waters Kevin
EVP, CFO
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-15$4.56/sh+17,747$80,926103,173 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-03-1536,01015,917 total
    Exercise: $4.52Exp: 2028-10-22Common Stock (36,010 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-03-1517,74753,243 total
    Exercise: $4.56Exp: 2029-12-11Common Stock (17,747 underlying)
  • Exercise/Conversion

    Common Stock

    2024-03-15$4.52/sh+36,010$162,76585,426 total
Footnotes (2)
  • [F1]The Stock Option was granted on October 23, 2018 and vested over a four year period.
  • [F2]The Stock option was granted on December 12, 2019 and vested over a four year period.

Issuer

PROCEPT BioRobotics Corp

CIK 0001588978

Entity typeother

Related Parties

1
  • filerCIK 0001653771

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 6:05 PM ET
Size
10.1 KB